New vaccines against tuberculosis: lessons learned from BCG immunisation in Brazil

Transactions of the Royal Society of Tropical Medicine and Hygiene

Volumn 102, Issue 7, 2008, Pages 628-630

  Antas, P R Z ^a   Castello Branco, L R R ^a  

^a INSTITUTO OSWALDO CRUZ   (Brazil)

Author keywords

BCG; Brazil; Immunisation; Routes; Tuberculosis; Vaccines

Indexed keywords

BCG VACCINE; DNA; RECOMBINANT VACCINE;

ABSENCE OF SIDE EFFECTS; BACTERIAL STRAIN; BRAZIL; DNA SEQUENCE; DRUG EFFICACY; HUMAN; IMMUNIZATION; IMMUNOLOGICAL TOLERANCE; INFECTION CONTROL; MYCOBACTERIUM BOVIS; MYCOBACTERIUM TUBERCULOSIS; REVACCINATION; REVIEW; SEQUENCE ANALYSIS; STRAIN DIFFERENCE; TUBERCULOSIS;

ADJUVANTS, IMMUNOLOGIC; BCG VACCINE; BRAZIL; DOSE-RESPONSE RELATIONSHIP, DRUG; DRUG DESIGN; HUMANS; IMMUNIZATION, SECONDARY; RURAL HEALTH; TREATMENT OUTCOME; TUBERCULOSIS, PULMONARY;

MYCOBACTERIUM BOVIS BCG;

EID: 44749090330     PISSN: 00359203     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.trstmh.2008.03.014     Document Type: Review

References (15)

1. Assis A. Novas perspectivas da vacinação contra a tuberculose pelo BCG. O. Hospital 38 (1950) 337-353
2. Barreto M.L., Cunha S.S., Pereira S.M., Genser B., Hijjar M.A., Yury Ichihara M., de Brito S.C., Dourado I., Cruz A., Santa'Ana C., and Rodrigues L.C. Neonatal BCG protection against tuberculosis lasts for 20 years in Brazil. Int. J. Tuberc. Lung Dis. 9 (2005) 1171-1173
3. Barreto M.L., Pereira S.M., and Ferreira A.A. BCG vaccine: efficacy and indications for vaccination and revaccination. J. Pediatr. (Rio J.) 82 3 Suppl. (2006) S45-S54
4. Benévolo-de-Andrade T.C., Monteiro-Maia R., Cosgrove C., and Castello-Branco L.R. BCG Moreau Rio de Janeiro: an oral vaccine against tuberculosis. Mem. Inst. Oswaldo Cruz 100 (2005) 459-465
5. Bricks L.F. Percutaneous or intradermal BCG vaccine?. J. Pediatr. (Rio J.) 80 (2004) 93-98 [in Portuguese]
6. Brosch R., Gordon S.V., Garnier T., Eiglmeier K., Frigui W., Valenti P., Dos Santos S., Duthoy S., Lacroix C., Garcia-Pelayo C., Inwald J.K., Golby P., Garcia J.N., Hewinson R.G., Behr M.A., Quail M.A., Churcher C., Barrell B.G., Parkhill J., and Cole S.T. Genome plasticity of BCG and impact on vaccine efficacy. Proc. Natl. Acad. Sci. USA 104 (2007) 5596-5601
7. Chen L., Wang J., Zganiacz A., and Xing Z. Single intranasal mucosal Mycobacterium bovis BCG vaccination confers improved protection compared to subcutaneous vaccination against pulmonary tuberculosis. Infect. Immun. 72 (2004) 238-246
8. Cosgrove C.A., Castello-Branco L.R., Hussell T., Sexton A., Giemza R., Phillips R., Williams A., Griffin G.E., Dougan G., and Lewis D.J. Boosting of cellular immunity against Mycobacterium tuberculosis and modulation of skin cytokine responses in healthy human volunteers by Mycobacterium bovis BCG substrain Moreau Rio de Janeiro oral vaccine. Infect. Immun. 74 (2006) 2449-2452
9. Das S.D., Narayanan P.R., Kolappan C., and Colston M.J. The cytokine response to bacille Calmette Guérin vaccination in South India. Int. J. Tuberc. Lung Dis. 2 (1998) 836-843
10. Hoft D.F., Brown R.M., and Belshe R.B. Mucosal bacille Calmette-Guérin vaccination of humans inhibits delayed-type hypersensitivity to purified protein derivative but induces mycobacteria-specific interferon-gamma responses. Clin. Infect. Dis. 30 Suppl. 3 (2000) S217-S222
11. Lotte A., Wasz-Hockert O., Poisson N., Dumitrescu N., Verron M., and Couvet E. BCG complications. Estimates of the risks among vaccinated subjects and statistical analysis of their main characteristics. Adv. Tuberc. Res. 21 (1984) 107-193
12. Monteiro-Maia R., Ortigao-de-Sampaio M.B., Pinho R.T., and Castello-Branco L.R. Modulation of humoral immune response to oral BCG vaccination by Mycobacterium bovis BCG Moreau Rio de Janeiro (RDJ) in healthy adults. J. Immune Based Ther. Vaccines 4 (2006) 4
13. Murphy D., Corner L.A., and Gormley E. Adverse reactions to Mycobacterium bovis bacille Calmette-Guérin (BCG) vaccination against tuberculosis in humans, veterinary animals and wildlife species. Tuberculosis (Edinb.) (2008) [Epub ahead of print]
14. Rodrigues L.C., Kerr-Pontes L.R., Frietas M.V., and Barreto M.L. Long lasting BCG protection against leprosy. Vaccine 25 (2007) 6842-6844
15. Xing Z., and Lichty B.D. Use of recombinant virus-vectored tuberculosis vaccines for respiratory mucosal immunization. Tuberculosis (Edinb.) 86 (2006) 211-217